FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:440-443 August 3, 2006 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Slide Presentation Perspective Perspective by Parker, A. A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Parker, A. A. PubMed Citation

The control and virtual elimination of measles in the United States is a public health success that has provided a model for immunization programs in other parts of the developed world. Before measles vaccination was introduced in the United States in the mid-1960s, more than half a million cases of measles were reported each year. Once a vaccine was developed, public health officials set out to use it to control the disease, envisioning eventual global eradication. By the mid-1970s, fewer than 50,000 cases were being reported annually in the United States, but a severe outbreak in Los Angeles in 1977 . . . [Full Text of this Article]

Source Information

Dr. Mulholland is a professor in the Infectious Disease Epidemiology Unit of the London School of Hygiene and Tropical Medicine, London.

This article has been cited by other articles:

• Ramachandran, A., Parisien, J.-P., Horvath, C. M. (2008). STAT2 Is a Primary Target for Measles Virus V Protein-Mediated Alpha/Beta Interferon Signaling Inhibition. J. Virol. 82: 8330-8338 [Abstract] [Full Text]  
• Poling, J. S., Offit, P. A. (2008). Vaccines and Autism Revisited. NEJM 359: 655-656 [Full Text]